A Study on Elathy Chooranam (Internal Medicine) and Sivappu Kukil Thylam (External Medicine) in the management of Kaanakadi (Urticaria)

An Open Label Single Arm Clinical Trial to evaluate the Effectiveness of Elathy Chooranam (Internal Medicine) and Sivappu Kukil Thylam (External Medicine) in the management of Kaanakadi (Urticaria) among patients reporting at Ayothidoss Pandithar Hospital, National Institute of Siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080424

Enrollment

Registered

2025-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L50- Urticaria

Interventions

Intervention1: Sivappu Kukil Thylam: External application for 40days Intervention2: Elathy Chooranam: Internal Medicine: Dose: 3 Tablets - Twice a day, Adjuvant - Warm water, Duration: 40 days Interve

Eligibility

Inclusion criteria

Inclusion criteria: Participants with clinical symptoms of itching, burning sensation, erythema, pale pink oedematous wheal formation, wheals surrounded by flare.

Exclusion criteria

Exclusion criteria: Evidence of any skin condition other than urticaria, angioedema, narcotic addicts, pregnancy and lactation, diabetes mellitus, hypertension.

Design outcomes

Primary

Measure	Time frame
Significant reduction in clinical symptoms based on Urticaria Activity Score over 7 days (UAS7) and clinical laboratory blood parameters such as IGE, AEC, ESR, CRPTimepoint: 3 Months -Screening 12 Months - Patient enrollment 3 Months -Outcome assessment	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactProf Dr R Madhavan

National Institute of Siddha

drmadhavanji@gmail.com9965561656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026